ArticleMolecular therapy. Nucleic acids2022

Efficient CRISPR-Cas9-mediated mutagenesis in primary human B cells for identifying plasma cell regulators.

Tuan Anh Le et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.